Insulin Human

Hyperinsulinism

Columbia UniversityUNKNOWNPhase 1Active

CC

44/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 32/ 100
Competitive Position: 81/ 100

Competitive context

17 Active assets in the Hyperinsulinism cohort.

Asset / Sponsor	Phase	Rating
Metformin Attikon Hospital	Phase 4	BB
Eudemine Injection Columbia University	Phase 2	B
Rosiglitazone New York Medical College	Phase 2	B
Insulin-Like Growth Factor I Children's Hospital of Philadelphia	Phase 2	B
Vigabatrin University of Arizona	Phase 2	CCC

View all 23 →

Same molecule, other indications

Insulin Human is also rated in:

dry eye syndromeActive

BB

Indicative · Phase 4

65 / 100

prediabetes syndromeActive

CC

Indicative · Phase 1

44 / 100

metabolic dysfunction-associated steatotic liver diseaseActive

CC

Indicative · Phase 1

42 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.